Xanthonolol: a calcium channel and beta-adrenoceptor blocker with vasodilating properties

Gen Pharmacol. 1993 Nov;24(6):1425-33. doi: 10.1016/0306-3623(93)90430-6.

Abstract

1. Xanthonolol (0.1-5.0 mg/kg, i.v.) reduced the blood pressure, heart rate, and L-isoproterenol (0.05 microgram/kg, i.v.)-induced tachycardia in rats. 2. In the isolated guinea-pig right atrium, xanthonolol (10(-6)-3 x 10(-4) M) produced long-lasting negative, inhibited L-isoproterenol-induced positive chronotropic effects, prevented the rate-increasing effects of increased extracellular Ca2+ (3.0-9.0 mM), and inhibited Ca2+ (3.0-9.0 mM)-induced heart rate-increase. 3. In the isolated guinea-pig thoracic aorta, the contractions induced by CaCl2 (0.1-5.0 mM) were inhibited by xanthonolol (10(-6)-10(-4) M). 4. Xanthonolol is suggested to have a calcium channel and beta adrenergic blocking effect with vasodilating properties.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology*
  • Animals
  • Aorta, Thoracic / drug effects
  • Blood Pressure / drug effects
  • Calcium Channel Blockers / pharmacology*
  • Calcium Chloride / pharmacology
  • Female
  • Guinea Pigs
  • Heart Rate / drug effects
  • In Vitro Techniques
  • Isoproterenol / antagonists & inhibitors
  • Isoproterenol / pharmacology
  • Male
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Myocardial Contraction / drug effects
  • Rats
  • Rats, Wistar
  • Vasodilator Agents / pharmacology*
  • Xanthenes / pharmacology*
  • Xanthones*

Substances

  • Adrenergic beta-Antagonists
  • Calcium Channel Blockers
  • Vasodilator Agents
  • Xanthenes
  • Xanthones
  • xanthonolol
  • Isoproterenol
  • Calcium Chloride